Disciplined Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-16
Closed -$7.11K 535
2023
Q2
$7.11K Sell
16
-1
-6% -$461 ﹤0.01% 362
2023
Q1
$7.82K Sell
17
-4
-19% -$1.9K ﹤0.01% 373
2022
Q4
$10.8K Buy
21
+1
+5% +$508 0.01% 316
2022
Q3
$9K Buy
20
+1
+5% +$478 ﹤0.01% 365
2022
Q2
$9K Buy
19
+2
+12% +$989 ﹤0.01% 383
2022
Q1
$8K Buy
+17
New +$7.77K ﹤0.01% 396

Other funds holding ELV

Disciplined Investments's ELV Position: Q3 2023 in Review

Disciplined Investments sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 16 shares — an estimated $7.11K sold.

Disciplined Investments first reported a position in ELV in Q1 2022 and held it in 6 quarters. The position peaked at $10.8K in Q4 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Disciplined Investments reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 16 Elevance Health shares in Q3 2023, an estimated $7.11K.
  • Disciplined Investments first reported a position in Elevance Health in Q1 2022 and held it in 6 quarters.
  • Disciplined Investments's Elevance Health position peaked at $10.8K in Q4 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.